Thursday, 15 October 2026European Markets
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· January 30, 2026

Carbon Capture, Utilization, and Storage Research Report 2026: $51.6 Bn Market Opportunities, Trends, Competitive Analysis, Strategies, Forecasts | Astute Analytica

View original at globenewswire.com
Carbon Capture, Utilization, and Storage Research Report 2026: $51.6 Bn Market Opportunities, Trends, Competitive Analysis, Strategies, Forecasts | Astute Analytica Chicago, Jan…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Enhanced oil recovery techniques in North America resulted in the capture of over 25 million tons of CO2 annually

    80% confidence
  • North America commands nearly 40% of the worldwide CCUS market share

    80% confidence
  • The global carbon capture, utilization, and storage (CCUS) market was valued at US$ 3.5 billion in 2023 and is projected to hit the market valuation of US$ 51.6 billion by 2050 at a CAGR of 10.49% during the forecast period 2024–2050

    80% confidence
  • By 2023, more than 30 countries had enacted policies or frameworks specifically targeting CCUS initiatives

    80% confidence
  • In 2023, the oil and gas industry commanded over 32.16% of the CCUS market share

    80% confidence
  • In 2023, the fossil fuels segment accounted for over 45.01% of the total CCUS market revenue share

    80% confidence
  • As of 2023, over 100 carbon capture projects worldwide are actively exploring ways to integrate carbon capture technologies with renewable energy sources

    80% confidence
  • In 2023, the oil and gas industry was responsible for capturing approximately 500 million metric tons of CO2 globally

    80% confidence
  • The 45Q Tax Credit offers up to approximately $50 per ton of CO2 sequestered

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Clinical Catalyst Season: Big-Pharma Data Flow, Regulatory Milestones, and a Thin AI-Drug Fringe
October 2026 conferences (EASD, IGCS, NACFC, HFSA) are producing a dense run of late-stage readouts from Novo Nordisk, Lilly, Roche, Bayer, Vertex and Galderma. Regulatory milestones are scheduled behind them: the ivonescimab BLA PDUFA date on 2026-11-14, FDA acceptance of Roche's vamikibart BLA, and Scholar Rock's EMA resubmission. The AI-and-finance angle is peripheral. It consists of the AI-designed drug Rentosertib and QAIAx, a speculative microcap whose trial claims (the QIII pilot, anticipated 2027-01-01, and a patent update) are forecasts and filings rather than data, so they warrant skepticism.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,375 source documents archived
Query this data → isubstrate.com
Carbon Capture, Utilization, and Storage Research Report 2026: $51.6 Bn Market Opportunities, Trends, Competitive Analysis, Strategies, Forecasts | Astute Analytica — Source | Via News | ViaNews EU